University of Kansas Medical Center
Kansas City, Kansas, 66160, United States
NCT Number: NCT01868087
The purpose of this study is determine if using Impact Advanced Recovery® before and after RC surgery helps reduce surgical complications.
Looking for future studies?
Notify Me40 year–90 year
Male
Interventional
Early Phase 1
Kansas City, Kansas, 66160, United States
Radical cystectomy (RC) is the removal of the entire bladder and nearby organs that may contain cancer cells. It is a major surgery that can lead to breakdown of proteins in the body and a decreased immune response, both of which increase the risk of illness and death. Poor nutrition status before RC surgery is linked to a higher rate of death after surgery. Therefore, it is important to eat a balanced diet before and after RC surgery to avoid negative outcomes.
Studies show that patients who drink a nutritional supplement that may enhance the immune system before and after gastro-intestinal surgery may have fewer infections and shorter hospital stays after surgery. Patients with cancer of the colon/rectum, stomach, and pancreas who drank a similar immune-enhancing nutritional supplement before and after surgery also had fewer infections.
The purpose of this study is to attain pilot data for a larger trial.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Change from Baseline to Day 30
Measure ability of Impact Advanced Recovery® to alter body's immune and inflammation response.
Time frame: Change from Baseline to 30 Days
measure of body weight and fat free mass between groups over course of the study
Time frame: Change from Baseline to 30 Days
count of total number of infections affecting study participants
Time frame: Change from Baseline to 30 Days
readmissions required for study partipants
Jill Hamilton-Reeves, PhD RD LD
Other
Impact Advanced Recovery® for Radical Cystectomy (RC) Patients
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03081858
Bladder Cancer, Bladder Cancer Cell Transitional
Tucson, Arizona, United States
View Trial DetailsNCT05578898
Bladder Cancer, Female Urogenital Diseases
Ann Arbor, Michigan, United States
View Trial DetailsNCT06395701
Bladder Cancer, Bladder Disease
Terrassa, Barcelona, Spain
View Trial DetailsNCT03307200
Bladder Cancer, Female Urogenital Diseases
Ghent, Belgium
View Trial Details